Akut mieloid leukémia (AML): vizsgálatok itt: Malajzia

1 trial · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Where

  Johor Bahru, Kuala Lumpur, Petaling Jaya, Subang Jaya

  Életkor

  12 év and over

  People

  468 worldwide

  Run by

  Syndax Pharmaceuticals

  See details and how to joinNCT07211958 · EU 2025-522279-27-00